Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2
Creator
Li, Minghua
Cherry, Sara
Lee, Jae
Dittmar, Mark
Jurado, Kellie
»more»
source
BioRxiv
abstract
There are an urgent need for antivirals to treat the newly emerged SARS-CoV-2. To identify new candidates we screened a repurposing library of ~3,000 drugs. Screening in Vero cells found few antivirals, while screening in human Huh7.5 cells validated 23 diverse antiviral drugs. Extending our studies to lung epithelial cells, we found that there are major differences in drug sensitivity and entry pathways used by SARS-CoV-2 in these cells. Entry in lung epithelial Calu-3 cells is pH-independent and requires TMPRSS2, while entry in Vero and Huh7.5 cells requires low pH and triggering by acid-dependent endosomal proteases. Moreover, we found 9 drugs are antiviral in lung cells, 7 of which have been tested in humans, and 3 are FDA approved including Cyclosporine which we found is targeting Cyclophilin rather than Calcineurin for its antiviral activity. These antivirals reveal essential host targets and have the potential for rapid clinical implementation.
has issue date
2020-06-19
(
xsd:dateTime
)
bibo:doi
10.1101/2020.06.19.161042
has license
biorxiv
sha1sum (hex)
63071296fcf911324bbe22bc97e2c0117911071a
schema:url
https://doi.org/10.1101/2020.06.19.161042
resource representing a document's title
Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2
schema:publication
bioRxiv
resource representing a document's body
covid:63071296fcf911324bbe22bc97e2c0117911071a#body_text
is
schema:about
of
named entity 'cells'
named entity 'antivirals'
named entity 'cells'
named entity 'cells'
named entity 'library'
»more»
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 12
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software